The Fast Money traders share their final trades of the day.» Read More
Customers love their food. But the CFO says there's little appetite for a stock split.
If you have a penchant for quizzes and such, Jim Cramer thinks this question could lead you to a solid stock idea.
Cramer often says that if you do homework, you can prosper by holding a relatively small number of stocks.
What to expect from Facebook's earnings conference call, with Bob Peck of SunTrust Robinson Humphrey.
The "Fast Money" traders debate the health of Facebook's quarterly earnings.
Facebook reported Q2 EPS of $0.42 ex-items on revenue of $2.91 billion. Martin Pyykkonen, Rosenblatt Securities; Colleen Taylor, TechCrunch reporter; Nicholas Carlson, Business Insider deputy editor; and Todd Schoenberger, J. Streicher Asset Management, discuss hesitance in the stock.
Bruce Jenkyn-Jones, head of listed equities at Impax Asset Management, says geopolitical events have shown the need for energy diversification. He selects his top "green" picks.
Results of a clinical trial of a breast cancer drug could make this company a takeover target, too, says CNBC's Jim Cramer.
CNBC's Jim Cramer says he is watching shares of Xilinx and explains why the credibility of the company is in question.
Jim Cramer explains what to watch ahead of the open, including Puma Biotechnology. Cramer says the stock could quadruple due to the results of a new drug trial.
Cramer thinks now is a good time to look at companies that have rallied post quarter, and then determine which could have more upside.
Had you followed Cramer into this stock, you’d be looking at upside. Serious upside.
“They are making statement about what people want to eat and, as a result, what investors should want to buy,” said Cramer.
Mad Money host Jim Cramer dissects what he calls 'abysmal' earnings from McDonald's. He's confident in Chipotle's organic growth.
Mad Money host Jim Cramer shares his best tips for handling the pressure during the height of the earnings season, and shares his opinions on hedge fund manager Bill Ackman's case against Herbalife.
The Fast Money traders share their final trades of the day.
Hedge fund manager Bill Ackman gave a presentation in NYC Tuesday on his case against Herbalife. The "Fast Money" traders share their predictions for the stock.
By reflecting on the worst of the market, Jim Cramer often finds valuable lessons that inform his decisions going forward.
"Sure, the company gave guidance that seemed lighter than expected, but that’s just Apple’s style,” Cramer said.
The "Fast Money" traders take a look at today's biggest market movers.